Access Insights and Strategy

We extract highly actionable insights from a variety of market access stakeholders leveraging unique and proven market access methodologies. Our approaches range from traditional, structured in-depth interviews (IDIs) to strategic advisory board models that combine deep critical thinking with creative and engaging meeting formats. We leverage our curated panel of market access stakeholders to select the best target for every research program. Our panel includes current and former US payers and hospital system stakeholders, as well as a range of emerging market access stakeholders. We also have global reach with a variety of market access stakeholders and influencers in the United Kingdom, Europe, Canada, and select markets in Asia and South America.

The market access ecosystem is nuanced and dynamic, with new connections forming constantly. We help our clients understand the ecosystem and sort market access accounts into segments that allow for tailored, purposeful, and effective engagement with customers. These projects can range from interactive “follow the dollar” assessments to robust, qualitative payer account segmentation leveraging a variety of data sources.

IDNs remain one of the most fascinating customer segments in the market access space given their position at the intersection of population management and individual patient care. As a result, IDNs require a thoughtful, well-informed approach to maximizing the commercial opportunity in this important segment. At Lumanity, we help our clients understand the IDN opportunity for their individual brands and create effective go-to market strategies that help them accomplish their access and commercial goals in the channel.

Achieving commercial success hinges on a thorough understanding of your competitors and the ability to anticipate and react to their future actions. We employ a series of methodologies to help our clients with competitive planning, ranging from traditional war-gaming to practical simulations that emphasize both clinical and economic positioning as well as potential contracting strategies and their interplay across competitors. Our approaches not only help our clients better anticipate competitor behavior, but they also allow our clients to gain alignment within their own organizations to execute against potential competitive threats at speed.

Pricing and contracting are two of the most important components that market access teams can deliver to the overall value proposition of their brands. At Lumanity, we bring deep qualitative and quantitative pricing and contracting expertise to support our clients across the lifecycle. From helping to set well-informed potential price bands and “bottoms-up” forecasts for early assets to supporting late-stage assets navigate new contracting dynamics and Medicare negotiations driven by the Inflation Reduction Act, Lumanity has the expertise and capabilities needed to partner with your brand for success.

Many new medical innovations are coming to market with profiles that challenge existing supply chain and reimbursement processes. Our experts can help clients map current buying processes and practice economics and chart new approaches to optimize access to new therapies.

Lumanity brings a highly differentiated combination of deep market access and health economics expertise. We leverage this combination to help clients share insights and find synergies across these important functions. Our Evidence Generation Summits have been recognized as a cutting-edge approach to build alignment across market access and HEOR teams while adhering to firewalls and required ways of working.

The market access landscape is in an historic period of evolution. Staying abreast of new policies, customer dynamics, and market trends is critical to have a high-performing market access organization. We help our clients examine the landscape for key changes that have the potential to impact their portfolios and partner to develop assessments and plans of action accordingly.